Related Experiment Video
Updated: Jan 19, 2026

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology
Published on: February 25, 2022
Epigenetics of pituitary tumors: Pathogenetic and therapeutic implications
Shereen Ezzat1, Sonia Cheng1, Sylvia L Asa2
1Department of Medicine, University of Toronto, The Endocrine Oncology Site Group, Princess Margaret Cancer Centre, and The Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada.
Abstract:
Genetic mutations involving oncogenes or tumor suppressor genes are relatively uncommon in human sporadic pituitary tumors. Instead, increasing evidence has highlighted frequent epigenetic alterations including DNA methylation, histone modifications, and enhanced miRNA expression. This review covers some of this evidence as it illuminates mechanisms of tumorigenesis and highlights therapeutic opportunities.
Insights
Genetic mutations are rare in sporadic pituitary tumors. Epigenetic changes like DNA methylation and altered miRNA expression are key drivers, offering new therapeutic targets.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Sporadic pituitary tumors often lack common genetic mutations in oncogenes or tumor suppressor genes.
- Epigenetic alterations are increasingly recognized as significant factors in pituitary tumor development.
Purpose of the Study:
- To review evidence on epigenetic alterations in human sporadic pituitary tumors.
- To elucidate the mechanisms of pituitary tumorigenesis driven by epigenetic changes.
- To highlight potential therapeutic strategies based on these findings.
Main Methods:
- Literature review of studies investigating epigenetic modifications in pituitary tumors.
- Analysis of data on DNA methylation patterns.
- Examination of histone modifications and microRNA (miRNA) expression profiles.
Main Results:
- Frequent epigenetic alterations, including DNA methylation and histone modifications, are observed in sporadic pituitary tumors.
- Enhanced microRNA (miRNA) expression is a common finding, suggesting its role in tumorigenesis.
- These epigenetic changes provide insights into the molecular pathways driving tumor formation.
Conclusions:
- Epigenetic dysregulation, rather than genetic mutations, is a primary mechanism in sporadic pituitary tumorigenesis.
- Understanding these epigenetic alterations opens avenues for novel therapeutic interventions.
- Targeting epigenetic modifications may offer a promising strategy for pituitary tumor treatment.
More Related Videos
12:34Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome
Published on: April 2, 2018
07:43Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Related Concept Videos
Mitogens and the Cell Cycle
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
The Tumor Microenvironment